Researchers evaluated the 1-year safety data on subcutaneous levodopa/carbidopa continuous infusion with ND0612, an investigational subcutaneous delivery system providing minimally invasive continuous infusion, in patients with Parkinson disease.
Your search for major depressive disorder returned 1 results
Active Filters
Click on a filter below to refine your search. Remove a filter to broaden your search.
-
Latest News Your top articles for Friday
For More Personalized News -
Haymarket Medical NetworkTop Picks
- Loading...
Continuing Medical Education (CME/CE) Courses